Sales & Marketing

Company aims to utilize technology for efficient Parkinson’s treatment.

An insightful discussion about how Meta's newest social media platform, Threads, is quickly adding another facet to the digital landscape for pharma marketers.

Pharma giant to serve as Team USA’s partner in prescription medicine and health equity.

Agency claims union would threaten a monopoly on programmatic advertising space.

Obtained assets expected to expand capabilities in RNA-based therapeutics.

Demand comes among antitrust agency’s recent denial of Amgen’s Horizon buyout.

Companies aim to discover novel molecules that promote precise delivery of nucleic acid.

Merger aims to advance RNA editing programs.

Cloud-based solution updates pharma regulatory and commercial teams ability to review text and content.

Organizations plan to accelerate development of models for biology and chemistry.

Funding to support development of company’s oral p300/CBP inhibitor.

Biotech to obtain exclusive option for patients with select tumors.

Partnership enables rights to utilize therapeutic’s intravitreal retinotropic R100* vector.

Agreement to focus on the treatment of patients with advanced head and neck cancer.

In this insightful Q&A, Aaron Noll, MD, MS, OptimizeRx's senior AI solutions engineer, sheds light on how healthcare professionals leverage various information channels, the type of data they seek, and the role of AI in personalizing and optimizing healthcare communication.

Expansion to include treatment for LDL-C reduction in patients with primary hyperlipidemia.

Medication reportedly worth more than $7 billion.

Healthcare stakeholders suggest system changes, proving therapeutic value.

Company to invest proceeds in further R&D efforts.

Medication is currently the only cleared drug shown to reduce disease progression.

Newly-issued final guidance focuses on language used when communicating quantitative efficacy or risk information.

Through the power of large language models and generative AI, pharma and biotech companies are transforming medical information delivery by offering direct, trustworthy, and accurate answers to patients and healthcare providers, significantly reducing time and frustration.

Prices not likely to change upon release.

Senior editor Fran Pollaro chats with Sharlene Jenner, vice president of engagement strategy, Abelson Taylor about the transformative impact and ethical considerations of AI in the pharmaceutical industry, emphasizing its potential in data analysis and marketing, while also highlighting the pioneering work of AI companies in advancing drug discovery.

Deal comes amid collaboration on encapsulated cell therapies.